Evidence map›Paper›PMID 36970683›Full record

ArticleFrontiers in microbiology2023

Characterization of the

Carolin J Schiffer, Christian Grätz, Michael W Pfaffl, Rudi F Vogel, Matthias A Ehrmann

Open access · goldFull text read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. BlihIA-A Novel Type I Restriction-Modification System fromInternational journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
  4. Genomic characterization of a multidrug-resistantFrontiers in microbiology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Carolin J SchifferChair of Technical Microbiology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Christian GrätzChair of Animal Physiology and Immunology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Michael W PfafflChair of Animal Physiology and Immunology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Rudi F VogelChair of Technical Microbiology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Matthias A EhrmannChair of Technical Microbiology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Technical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Restriction modification (RM) systems are known to provide a strong barrier to the exchange of DNA between and within bacterial species. Likewise, DNA methylation is known to have an important function in bacterial epigenetics regulating essential pathways such as DNA replication and the phase variable expression of prokaryotic phenotypes. To date, research on staphylococcal DNA methylation focused mainly on the two species

Indexed as

DNA methylationepigeneticsmethylomemethyltransferases (MTases)restriction modification systemsStaphylococcus xylosus

Identifiers

PMID36970683
PMCPMC10030836
OpenAlexW4323567571

What Socratic holds

Textfull text, public
LicenceCC BY
reference markers read3
measurements read51
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.